These studies suggest that TMEM88 may have an important regulatory role in the process of ovarian cancer resistance and may also be used to identify epigenetic modifiers associated with platinum resistance, which may provide new clues and insights for predicting ovarian cancer recurrence and overall cancer patient survival. This evidence concerns the gene TMEM88 and cancer.